Is neuromyelitis optica without AQP4-IgG a T-cell mediated disease? Insights from checkpoint inhibitor immune-related adverse events

Publication date: Available online 15 August 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Salam Nasralla, Hesham Abboud
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research